Cia Brasileira de Distribuicao

Companhia Brasileira de Distribuição engages in the retail of food, clothing, home appliances, and other products through its chain of hypermarkets and supermarkets. It operates through the Food Retail, and Cash and Carry segments. The Food Retail segment sells food and non-food products to individual consumers. The Cash and Carry segment retails food and some non-food products to resellers, intermediate consumers, and retail customers through the Assaí banner. The company was founded in 1948 and is headquartered in Sao Paulo, Brazil.

Earnings data Q4 2019

Earnings data Q1 2020

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q3 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Gap Inc

Nordstrom

Kohl's

Tapestry

Ulta Beauty

Walgreens

The retail environment is changing once again. These seven companies are having trouble adjusting.

7 Retail Stocks to Keep Your Distance From

Companhia Brasileira (CBD) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

Looking for Value? Why It Might Be Time to Try Companhia Brasileira (CBD)

Companhia Brasileira de Distribuicao has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

Companhia Brasileira de Distribuicao Enters Oversold Territory

Companhia Brasileira de Distribuicao (CBD) CEO Peter Estermann on Q4 2019 Results - Earnings Call Transcript

Companhia Brasileira de Distribuicao (CBD) CEO Peter Estermann on Q3 2019 Results - Earnings Call Transcript

Companhia Brasileira's (CBD) reports strong Assai unit sales in the third quarter of 2019. E-commerce sales at Multivarejo surge.

Companhia Brasileira (CBD) Q3 Earnings & Revenues Rise Y/Y

Companhia Brasileira (CBD) is battling macroeconomic headwinds and hurdles related to high investment costs. However, the Assai segment continues to stand strong.

Companhia Brasileira in Rough Water, Assai Unit a Respite

Companhia Brasileira de Distribuição (CBD) Q2 2019 Results - Earnings Call Transcript

Companhia Brasileira's (CBD) Assai segment is a major growth driver. Also, the company is on track with its pilot projects.

Companhia Brasileira to Gain on Digital Transformation & More

Walmart

CBD vs. WMT: Which Stock Is the Better Value Option?

Companhia Brasileira's (CBD) Q1 performance gains from consistent growth in the Multivarejo and Assai units.

Strong Units Fuel Companhia Brasileira's (CBD) Q1 Earnings

Companhia Brasileira's (CBD) Assai and Multivarejo units are likely to be the key drivers in Q1. Additionally, digital endeavors and focus on pilot projects are likely to aid the quarterly results.

Companhia Brasileira (CBD) Q1 Earnings to Gain on Solid Units

CBD or WMT: Which Is the Better Value Stock Right Now?

Strong deep-value investment found from targeting Brazil's key non-cyclical consumer sector benefiting from rising real wages, projected 2x current GDP growth, increased employment, and a new business-friendly regime under Bolsonaro.

CBD: Long The Brazilian Consumers And Short The EM Risk

Tenet Healthcare

New Frontier Data projects the medical market to grow at a 12.6% compound annual growth rate through 2025, from $5.0 billion in 2017 to an estimated $12.9 billion in 2025.

New Frontier Data: Ask Our Experts, 4/14/2019

Companhia Brasileira (CBD) is gaining from the Assai unit, Pilot Projects and strategy for 2018-2020.

Companhia Brasileira Up 16% in 3 Months: Will Momentum Stay?

News for Cia Brasileira de Distribuicao Stock (CBD)